NCT03205696View on ClinicalTrials.gov

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

July 20, 2021

Study Completion Date

November 30, 2023

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

Antiretrovirals

The antiretroviral (ARV) regimen provided by the clinician must follow DHHS guidelines for antiretroviral naïve adolescents and adults

Trial Locations (3)

70112

Tulane University, New Orleans

90025

University of California, Los Angeles, Los Angeles

90069

Los Angeles LGBT Center, Los Angeles

All Listed Sponsors
collaborator

Los Angeles LGBT Center

OTHER

collaborator

Tulane University

OTHER

lead

University of California, Los Angeles

OTHER

NCT03205696 - Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection | Biotech Hunter | Biotech Hunter